Uso de octreotide (análogo de somatostatina) en un caso de quilotórax bilateral secundario a linfoma: Report of one case / Octreotide for bilateral chylothorax secondary to lymphoma. Report of one case
Rev. méd. Chile
;
133(12): 1473-1476, dic. 2005. graf
Artículo
en Español
| LILACS
| ID: lil-428531
ABSTRACT
Since chylothorax is uncommon and has multiple causes, its best treatment choice is not clear. Recent reports show that octreotide is useful in the treatment of chlylothorax secondary to cancer or caused by surgical procedures. We report a 21 years old male with a chylothorax secondary to a non Hodgkin lymphoma. Treatment with octreotide changed the color and triglyceride content of pleural effusion. Serum albumin and proteins increased and the effusion subsided after the second cycle of chemotherapy with CHOP. Thus octreotide was discontinued on the 27th day of therapy and pleural drainages were whithdrawn. He was discharged in good conditions, 38 days after admission.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Linfoma no Hodgkin
/
Fármacos Gastrointestinales
/
Octreótido
/
Quilotórax
Tipo de estudio:
Estudio de etiología
Límite:
Adulto
/
Humanos
/
Masculino
Idioma:
Español
Revista:
Rev. méd. Chile
Asunto de la revista:
Medicina
Año:
2005
Tipo del documento:
Artículo
País de afiliación:
Chile
Institución/País de afiliación:
Universidad Austral de Chile/CL
Similares
MEDLINE
...
LILACS
LIS